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Abstract: Compared to low doses of gamma irradiation (γ-IR), high-charge-and-energy (HZE)
particle IR may have different biological response thresholds in cardiac tissue at lower doses, and
these effects may be IR type and dose dependent. Three- to four-month-old female CB6F1/Hsd
mice were exposed once to one of four different doses of the following types of radiation: γ-IR 137Cs
(40-160 cGy, 0.662 MeV), 14Si-IR (4-32 cGy, 260 MeV/n), or 22Ti-IR (3-26 cGy, 1 GeV/n). At 16 months
post-exposure, animals were sacrificed and hearts were harvested and archived as part of the NASA
Space Radiation Tissue Sharing Forum. These heart tissue samples were used in our study for RNA
isolation and microarray hybridization. Functional annotation of twofold up/down differentially
expressed genes (DEGs) and bioinformatics analyses revealed the following: (i) there were no clear
lower IR thresholds for HZE- or γ-IR; (ii) there were 12 common DEGs across all 3 IR types; (iii) these
12 overlapping genes predicted various degrees of cardiovascular, pulmonary, and metabolic diseases,
cancer, and aging; and (iv) these 12 genes revealed an exclusive non-linear DEG pattern in 14Si- and
22Ti-IR-exposed hearts, whereas two-thirds of γ-IR-exposed hearts revealed a linear pattern of DEGs.
Thus, our study may provide experimental evidence of excess relative risk (ERR) quantification of
low/very low doses of full-body space-type IR-associated degenerative disease development.
Keywords: heart; space radiation; gene expression; gamma radiation; NASA; female mice
1. Introduction
During future exploration-type space missions, astronauts could be exposed to doses
of space-type radiation (IR) (~0.4–0.5 Gy) from galactic cosmic rays (GCR), especially
during Mars missions, where astronauts would not have access to comprehensive health
care services for at least 2–3 years [1,2]. Emerging evidence suggests that during deep-space
missions, each cell in an astronaut’s body could be traversed by a proton every 3–4 days,
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helium nuclei every few weeks, and high-charge-and-energy (HZE) nuclei (e.g., C, O,
Si, Ti, Fe) every few months [3,4]. Since most experienced astronauts are middle-aged
(average age is 46 years, range is 33 to 58 years of age), they are at risk for developing
severe, adverse cardiovascular (CV) and other degenerative diseases both during long
space missions as well as later in life [5]. Others and our own NASA-funded published
data provided experimental evidence of the effects of low-dose proton and HZE-IR on the
short- and long-term alteration in cardiac function, cardiomyocyte morphology, and the
associated underlying molecular mechanisms [6–10]. Here, we provide for the first time
the transcriptome analysis of mouse hearts exposed to low and very low doses of gamma-
(137Cs), silicon- (14Si), and titanium- (22Ti) ion irradiation (IR). Animal numbers per each
irradiated group were selected by power analysis to assure statistical significance after
low dose radiation exposures. Our results show that 16 months after a single low- or very
low dose IR exposure, the gene expression in the heart tissue is significantly differentially
regulated compared to the sham-treated, non-irradiated controls, suggesting there are
long-term effects on dysregulation of varying molecular pathways that are associated with
various degrees of CV, pulmonary, and metabolic diseases, as well as biological processes,
including abnormal circadian rhythms, cancer, Hutchinson–Gilford progeria syndrome,
etc. Thus, our study may provide additional experimental evidence of the level of gene
expression for estimation of excess relative risk (ERR) for the development of CV and other
diseases due to exposure to low or very low doses of whole-body space-type IR.
2. Materials and Methods
2.1. Animal Procedures
We used NASA Space Radiation Tissue Sharing Forum–archived samples of female
CB6F1/Hsd mice from experiments conducted and published by Drs. Polly Chang and
Eleanor Blakely for evaluation of IR-induced carcinogenesis in the mouse Harderian
gland [11]. Detailed experimental protocols were previously published by Chang et al. [11].
Briefly, female CB6F1/Hsd mice were obtained from Harlan Laboratories Inc. (Indianapolis,
IN, USA). For each study, 100–120-day-old female mice were shipped directly from the
vendor to Brookhaven Laboratory Animal Facility (BLAF; Upton, New York, NY, USA)
approximately 1 week before irradiation. Mice were randomized by weight immediately
prior to whole-body particle IR exposure. After exposure, mice were shipped to the
animal facility at the Lawrence Berkeley National Laboratory (LBNL) and maintained
for 16 months. The 16-month period was chosen as it coincides with the time frame for
Harderian gland tumor development. All procedures were compliant with the standards of
the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health
and approved by the Animal Care and Use Committees at Lawrence Berkeley National
Laboratory (Berkeley, CA, USA), Brookhaven National Laboratory (BNL) (Upton, NY,
USA), and SRI International (Menlo Park, CA, USA, which included established diurnal
room lights on/off cycles).
2.2. Irradiation Procedures
Detailed experimental protocols were previously published by Chang et al. [11].
Briefly, female CB6F1/Hsd mice (n = 5/group) were irradiated with low and very low doses
of HZE-IR at the NASA Space Radiation Laboratory (NSRL) at the BNL. Dosimetry studies,
including depth–dose and dose–uniformity measurements, were conducted by beamline
physicists. Unanesthetized animals were briefly held in plastic boxes (40 × 40 × 73 mm3)
containing numerous holes to provide abundant airflow. Animals were irradiated for
<1 min with a single, full-body HZE-IR dose (≤0.5 Gy) of 260 MeV/n silicon (14Si, linear
energy transfer [LET] ≈ 70 keV/µm) and 1000 MeV/n titanium (22Ti, LET ≈ 100 keV/µm).
As another control group, a separate cohort of animals was irradiated with 137Cs γ-ray that
served as a low-LET reference radiation. Table 1 depicts beam energies, doses, and LET
used in these studies. Control sham-treated animals were placed in clear plastic holders for
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equivalent exposure times but were not irradiated. Similar to irradiated mice, control mice
were also maintained unanesthetized.
Table 1. Ionizing radiation types. Beam energies, doses, and LET used in this study.



















2.3. Tissue Collection and Sample Processing
Animals were sacrificed 16 months after a single dose of full-body IR with the corre-
sponding ions and doses (Table 1). Gross observations of all tissues were conducted during
necropsy and recorded. Hearts from control non-tumor-bearing mice were snap-frozen in
liquid nitrogen by members of Drs. Chang and Blakely’s research team [11] and archived
as part of NASA’s Space Radiation Tissue Sharing Forum. These archived heart tissue
samples were utilized for our current gene expression study.
2.4. RNA Extraction
Total RNA was isolated from snap-frozen heart tissues using the RNeasy Mini Kit
(Qiagen, Germantown, MD, USA) according to the manufacturer’s protocol. Briefly, heart
tissues were lysed and homogenized in the presence of a highly denaturing guanidine-
thiocyanate-containing buffer, which immediately inactivates RNAses to ensure purifica-
tion of intact RNA. Ethanol (70%) was added to provide appropriate binding conditions.
The homogenates were then applied to a RNeasy Mini spin column, where the total RNA
binds to the membrane and contaminants are efficiently washed away. High-quality RNA
was eluted using molecular-grade water (RNAse/DNAse free). RNA concentrations were
assessed using a Nanodrop ND-1000 spectrophotometer (NanoDrop Technologies, Wilm-
ington, DE, USA). Quality assessment was performed using Agilent 2200 TapeStation
(Agilent Technologies, Palo Alto, CA, USA) prior to qRT-PCR and microarray analysis.
2.5. Microarray Analysis
Linear messenger RNA (mRNA) amplification was achieved using the Affymetrix
WT-Plus kit (Affymetrix, Santa Clara, CA, USA) according to the manufacturer’s guidelines.
Briefly, 100 ng of RNA from each sample was used to generate amplified and biotinylated
complimentary DNA (cDNA) according to the guidelines of the Affymetrix WT-Plus
kit. Target denaturation was performed at 99 ◦C for 5 min. cDNA was then hybridized
to the Clariom S Mouse Array (Affymetrix, Santa Clara, CA, USA) for 16 h at 45 ◦C
while being rotated at 60 rpm. Arrays were then washed and stained using GeneChip
Fluidics Station 450 (Affymetrix, CA, USA) and subsequently scanned with Affymetrix
Gene Chip Scanner 3000 using Command Console software. Signal space transformation
(SST) normalization of raw data was performed using Expression Console software v 1.41.
(provided by Affymetrix). GeneSpring 14.9 software (Agilent, Santa Clara, CA, USA) was
used to identify differentially expressed transcripts between experimental and control
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groups. Of note, samples were processed for microarrays in two batches: first, 3 samples
for each condition (n = 36) and then 2 samples for each treatment condition (n = 24) for a
total of 60 samples representing 5 animals per each ion/dose.
2.6. Batch Examination and Correction
Principal components analysis (PCA) was used to identify batch effects by examining
patterns in plots of the first two principal components. Three methods for batch effect
adjustment were used: (1) Combat implemented in the sva R package [12], (2) remove
BatchEffect implemented in the limma R package [13], and (3) harman implemented in
the Harman R package [14]. Changes in batch effect contribution after adjustment were
assessed using the pvca R package [15].
2.7. Microarray Data Preprocessing
Background correction, conversion of signal intensity to log2-transformed expres-
sion values, and quantile normalization were performed on microarray raw CEL files
using the Robust MultiArray Average (RMA) algorithm implemented in the limma R
package [13]. Microarray probe IDs were converted to Entrez IDs using annotate and
clariomsmousetranscriptcluster.db R packages.
2.8. Analysis of Differential Gene Expression
Differentially expressed genes (DEGs) between control and each irradiated group
were identified using limma package [13]. Relaxed adjusted p-values of <0.25 were selected
as a cutoff for up- and downregulated genes, which is reasonable for finding an adequate
amount of DEGs for further validation and functional gene set analysis. Functional annota-
tion of DEGs was performed with the enrichR R package, which contains 35 human and
rodent gene set libraries (Supplementary Table S1) [16]. The Enrichr gene set enrichment
method is based on a combined score calculated from a proportional test (Fisher’s exact
test) and the z-score of deviation from the expected rank for each term in each gene set
library (see original publications for details [16]). Adjusted p-values of < 0.05 were selected
as a cutoff for over-represented gene sets. The lists of all differentially expressed genes are
provided in Supplementary Table S2.
2.9. Analysis of Dose-Dependent Changes in Gene Expression
To evaluate the patterns of gene expression changes in response to increasing doses
of irradiation, we performed linear and non-linear regression analysis using functions
from stats and splines R packages, respectively. For each gene, both linear and non-linear
regression models were fitted. The fit was considered significant if the model-adjusted
p-value was less than 0.25, and the fit type was assigned based on the highest R-squared
value between two models for each gene.
2.10. Portrayal of Transcriptome Landscapes
Transcriptome analysis was performed using the self-organizing map (SOM) machine
learning approach implemented in the oposSOM R package [17]. The SOM approach repre-
sents dimension reduction that translates 20,426 gene expression profiles in 72 samples into
1600 metagenes, each representing a cluster of genes with similar profiles of expression
across samples. The metagene expression values of each sample are visualized (expression
portrayal) by arranging them into a two-dimensional 40× 40 grid and using maroon to
blue colors corresponding to maximum to minimum expression values in each of the
portraits [18]. The oposSOM R package also offers a variety of tools for downstream analy-
ses, including function mining, modular feature selection, sample stratification, diversity
analysis, and phenotype mapping [17]. The limma-batch-effect-corrected gene expression
data were used as input data. For these serial analyses, all control animals were combined
into one group.
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2.11. qRT-PCR
The expression levels of the Arntl, Cdkn1a, Per3 Slc41a3, and Bhlhe41 transcripts were
measured by quantitative real-time polymerase chain reaction (qRT-PCR). Briefly, total
cellular RNA was isolated from mouse heart tissues across all samples using the miRNeasy
Mini Kit (Qiagen), as previously described. The High-Capacity cDNA Reverse Transcrip-
tion Kit (Applied Biosystems, 4368814) was used to generate cDNA according to the manu-
facturer’s instructions. Quantitative RT-PCR was performed using an Applied Biosystems
7700 apparatus. The relative expression levels of the target gene mRNAs were calculated
by the comparative CT method. Differences in CT values were calculated for each target
mRNA after subtracting the mean value of 18S rRNA (relative expression = 2−∆CT) [19].
Data were normalized using 18S ribosomal RNA (rRNA). Forward and reverse primer
sequences are provided in Table 2.
Table 2. Quantitative RT-PCR primers used in this study.
Gene Primer
ARNTL
Probe-/56-FAM/ACC TGC TCC/ZEN/AGT GTT TCC TCA TCA/3IABkFQ/
R-ATC CAC AGC TAG CCC AAA C
F-CCA CCT CAG AGC CAT TGA TAC
Slc41a3
Probe-/56-FAM/CTG GTT TCT/ZEN/GTG CCT CCC TGA CTG/3IABkFQ/
R-CAC TGA GGA CAT GAG GGA AAG
F-CTT CTT CCT GGA CTG GTT ACT G
Cdkn1a
Probe-/56-FAM/CAG CCT AGA/ZEN/ACA GGG ATG GCA GTT/3IABkFQ/
R-GAG TCG GGA TAT TAC GGT TGA G
F-CCA GCT AGG ATG ACA GTG AAG
PER3
Probe-/56-FAM/AGC CGG AAG/ZEN/GTC TCC TTC ATC ATT/3IABkFQ/
R-TGG ACT CGT TCG GAC TTT ATG
F-GCA CTC AGA ACG GAG AGT ATG
Bhlhe41
Probe-/56-FAM/AAC CGG AAG /ZEN/CCA CAG CTC ATA CAT/3IABkFQ/
R-TGC CTG ACT TTC TTC CCT TAC
F-TGA CTG TGA CAA GCT GAC TG
2.12. Gene Enrichment Analyses
After the identification of the 12 common regulated genes (Spon2, Adam19, Arntl,
Cdkn1a, Cry2, Per2, Per3, Wee1, Rcan1, Slc41a3, Errfi1, and Bhlhe41) across all 3 radiation
types (137Cs, 14Si, and 22Ti), gene enrichment analysis was repeated using the ENRICHR
resource (http://amp.pharm.mssm.edu/Enrichr/, accessed 09/2020), an integrative web-
based gene list enrichment analysis tool that includes the 2019 Kyoto Encyclopedia of Genes
and Genomes (KEGG) Mouse database and the ChEA 2016 gene library for identification
of enriched terms and upstream transcription factors, respectively. The clustergrammer
shows heatmaps of enriched terms as columns.
2.13. Statistical Analysis of qPCR Results
Data are presented as the mean ± standard error of the mean (SEM). mRNA expression
levels of Arntl, Cdkn1a, Per3, Slc41a3, and Bhlhe41 between non-exposed and exposed
animals were analyzed using one-way analysis of variance with the Bonferroni correction
for comparisons between >2 groups. Statistical analysis was performed using GraphPad
Prism 6, version 6.07 (GraphPad Software, Inc., La Jolla, CA, USA). Differences were
considered statistically significant at p < 0.05.
3. Results
3.1. Data Collection, Pre-Processing, and Mapping
Since samples were processed for microarray analyses in two separate batches, we first
performed a batch effect assessment. PCA clearly showed that samples were divided into
two clusters. To minimize the observed effects on gene expression values, we performed
batch effect removal using methods described in the Batch Examination and Correction sec-
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tion of Materials and Methods. Assessment of batch-related effects with principal variance
component analysis showed the best adjustment and was done by limma (Supplementary
Figure S1A–E), and these data were used for differential gene expression analysis.
Next, we performed a portrayal of transcriptome landscapes for studied groups using
the SOM approach (Supplementary Figure S2). This method projects gene expression data
onto a two-dimensional grid of 40 × 40 pixels (SOM portraits) and allows for visualization
of clusters of up- and downregulated genes as spot-like structures on a map of red or blue
color, respectively. Inspection of deregulated spot distribution on the group-centered SOM
portraits demonstrated that radiation exposure triggers variations in the transcriptome
landscape compared to untreated animals. Moreover, it could be noted that the highest
variability of gene expression changes is associated with the particle type (Supplementary
Figures S2 and S3). Less pronounced yet visible differences in transcriptome landscapes
were also associated with particle exposure dosage. As these results warrant further
exploration, we performed a detailed analysis of DEGs and functional annotation analysis.
3.2. Different Gene Expression in Mouse Heart Tissue Following 137Cs Irradiation
We evaluated DEGs in mouse hearts exposed to different doses of 137Cs-IR (Figure 1A–G).
The analysis revealed changes in DEGs in particle-exposed animals vs. controls (adjusted
p < 0.25). We identified a clear dose-dependent increase in the number of DEGs in 137Cs-
IR-exposed mouse hearts. The highest number of DEGs (529 genes, 241 upregulated and
288 downregulated) was observed after the highest dose, 160 cGy 137Cs-IR (Figure 1A–C,G
and Supplementary Spreadsheet_Cs_DEG_Up_Down). Conversely, the lowest number
of DEGs was seen in 40 cGy 137Cs-IR-exposed mouse hearts, where we found 47 DEGs,
of which 32 were upregulated and 15 downregulated (Figure 1A–D and Supplementary
Table S3). After 80 cGy 137Cs-IR, we identified 104 DEGs, of which 60 were upregulated and
44 downregulated (Figure 1A–C,E and Supplementary Table S3). After 120 cGy 137Cs-IR,
we found 157 DEGs, of which 75 were upregulated and 82 downregulated (Figure 1A–C,F
and Supplementary Table S3). Overall, 10 overlapping genes were common for all four
doses of 137Cs-IR (Figure 1B). Of these 10 genes, 8 were upregulated (Dbp, Gstt2, Pik3ip1,
Tspan4, Tcap, Stc2, P2rx7, and Nr1d2) and 2 were downregulated (Errfi1 and Arntl). These
10 common genes are implicated in the modulation of circadian rhythms [20–22], regula-
tion of muscle cell differentiation and locomotor activity [23], cardiac hypertrophy [24],
metabolism [23,25,26], oxidative stress [27–29], inflammation [30–32], and tumorigene-
sis [23,33–36].
3.3. Different Gene Expression in Mouse Heart Tissue Following 14Si Irradiation
Next, we evaluated the gene expression changes in mouse hearts subjected to 14Si-IR
(260 MeV/n) exposure at varying doses. The analysis revealed significant changes in
DEGs (adjusted p < 0.25). Notably, the highest number of DEGs (72 genes, 40 upregulated
and 32 downregulated) was observed in 14Si-IR-exposed mice after the lowest dose of
4 cGy (Figure 2A–D and Supplementary Table S4), with no overlapping genes between
any of the varying 14Si-IR doses (Figure 2B). In mouse hearts exposed to 8 cGy 14Si-IR, we
found 39 DEGs, of which 20 were upregulated and 19 downregulated (Figure 2A–C,E and
Supplementary Table S4). Surprisingly, we did not find any DEGs in the 16 cGy 14Si-IR
groups (Figure 2A–C), whereas after 32 cGy of 14Si-IR, we detected 43 DEGs, of which 18
were upregulated and 25 downregulated (Figure 2A–C,F and and Supplementary Table S4).
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Figure 1. Different gene expression in mouse heart tissue following 137Cs-gamma irradiation: (A) bar graphs showing
differentially expressed genes in the mouse heart tissue at different 137Cs (Cs, cesium) doses and (B) Venn diagram depicting
the number of differentially expressed genes in the mouse hearts across different doses of 137Cs irradiation. Colors in
the diagram represent genes putatively affected by the following 137Cs dose exposure: blue circles correspond to 40 cGy,
green circles to 80 cGy, yellow circles to 120 cGy, and purple circles to 160 cGy. (C) Table depicting the number of up- and
downregulated genes at different 137Cs-IR doses in the heart tissue and (D–G) heat maps showing differentially expressed
genes at different 137Cs-IR doses. Relative expression values are indicated on the color key and increase in value from blue
to red (n = 5/group).
Cells 2021, 10, 387 8 of 22
Figure 2. Different gene expression in mouse heart tissue following 14Si irradiation: (A) bar graphs showing differentially
expressed genes in mouse heart tissue after exposure to different 14Si (Si, silicon) doses and (B) Venn diagram depicting
the number of differentially expressed genes in mouse hearts across different doses of 14Si irradiation exposure. Colors
in the diagram represent genes putatively affected by the following 14Si dose exposure: blue circles correspond to 4 cGy,
green circles to 8 cGy, yellow circles to 16 cGy, and purple circles to 32 cGy. (C) Table depicting the number of up- and
downregulated genes at different 14Si-IR doses in the heart tissue and (D–F) heat maps showing differentially expressed
genes at different 14Si-IR oses. Relative expression values are indicated on the color key and increase in value from blue to
red (n = 5/group).
3.4. Different Gene Expression in Mouse Heart Tissue Following 22Ti Irradiation
Further analysis of DEGs in mouse hearts subjected to different doses of 22Ti-IR
(1000 MeV/n) revealed significant changes in DEGs (adjusted p < 0.25). The highest num-
ber of DEGs (460 genes, 234 upregulated and 226 downregulated) was observed after a
very low dose of 6.5 cGy 22Ti-IR (Figure 3A–C,E and and Supplementary Table S5). We
identified 49 overlapping DEGs between the 6.5 and 13 cGy 22Ti-IR groups (Figure 3B). At
the lowest dose of 3 cGy 22Ti-IR, we found only 2 DEGs, of which 1 was upregulated and
1 downregulated (Figure 3A–D and and Supplementary Table S5). In the hearts of 13 cGy
22Ti-IR-exposed mice, we found 108 DEGs, of which 55 were upregulated and 53 down-
regulated (Figure 3A–C,F and Supplementary Table S5). Surprisingly, we did not detect
any DEGs with ≥twofold change in mouse hearts subjected to the highest dose of 26 cGy
22Ti-IR (Figure 3A–C). Similar to our previous findings after different doses of 14Si-IR, we
did not find any overlapping DEGs between the four 22Ti-IR doses (Figures 2B and 3B).
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Figure 3. Different gene expression in mouse heart tissue following 22Ti irradiation: (A) bar graphs showing differentially
expressed genes in mouse heart tissue after exposure to different 22Ti (Ti, titanium)-IR exposure. Colors in the diagram
represent genes putatively affected by the following 22Ti dose exposure: blue circles correspond to 3 cGy, green circles to
6.5 cGy, yellow circles to 13 cGy, and purple circles to 26 cGy. (B) Venn diagram depicting the number of differentially
expressed genes in mouse hearts across different doses of Ti radiation exposure. Colors in the diagram represent genes
putatively affected by the following Ti dose exposure: blue circles correspond to 3 cGy, green circles to 6.5 cGy, yellow circles
to 13 cGy, and purple circles to 26 cGy. (C) Table depicting the number of up- and downregulated genes after exposure to
different 22Ti-IR doses in the heart tissue and (D–F) heat maps showing differentially expressed genes at different 22Ti-IR
doses. Relative expression values are indicated on the color key and increase in value from blue to red (n = 5/group).
3.5. Common Differentially Expressed Genes across All Radiation Types
We identified 12 overlapping genes that were common for all three types of IR and
were detected in at least one or more IR doses for each ion (Figure 4A–E). These 12 overlap-
ping genes are associated with a variety of biological and physiological processes, including
food intake, body weight, sleep alterations, circadian rhythms, inhibition of angiogenesis
and myogenesis, locomotor activity, metabolism, gluconeogenesis, and lipogenesis behav-
ior, as well as susceptibility to chronic diseases such as hypertension, diabetes, obesity,
infection, and cancers of different organs. With regard to their subcellular localization,
the majority of the 12 common DEGs are distributed in the nucleus (83%), cytosol (42%),
plasma membrane (25%), and extracellular (47%) (Table 3). These genes are associated
with the regulation of many processes within the organelles, including kinase binding
(Cdkn1a, Cry2, Errfi1, Per2, Per3), transcription regulating activities (Arntl, Bhlhe41, Cry2,
Per2, Spon2), histone deacetylase binding (Bhlhe41, Per2), SH3 domain binding (Adam19,
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Errfi1), nuclear hormone receptor binding (Cry2, Per2), protein kinase activity (Wee1), and
cation transmembrane transporters (Slc41a3) (Table 4). The top intracellular pathways of
the 12 overlapping genes were associated with circadian rhythms and entrainment (Arntl,
Cry2, Per2, Per3, Bhlhe41), the cell cycle (Cdkn1a, Wee1), the oxytocin signaling pathway
(Cdkn1a, Rcan1), and transcriptional misregulation in cancer (Cdkn1a, Per2) (Table 5).
Figure 4. Overlapping differentially expressed genes: (A) Venn diagram depicting the overlap of enrichment terms amongst
three different radiation exposure groups (137Cs, 14Si, and 22Ti) compared to the control group. In the diagram, blue circles
represent genes putatively affected by long-term 137Cs exposure, yellow circles represent genes influenced by 14Si exposure,
and green circles represent those affected by 22Ti exposure. (B) Table depicting 12 commonly expressed genes in one or more
of all radiation-type exposures and (C–E) microarray data analysis showing heat maps of the 12 overlapping commonly
expressed genes in different radiation groups/doses. Relative expression values are indicated on the color key and increase
in value from blue to red (n = 5/group).
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Table 3. Cellular localization of 12 overlapping differentially expressed genes.
Gene Name Extracellular Plasma Membrane Nucleus Cytosol Human Protein Atlas
Spon2 Y Plasma proteins, predicted membrane proteins, predicted secreted proteins
Adam19 Y Y Plasma proteins, predicted membrane proteins
Arntl Y predicted intracellular proteins, transcription factors
Cdkn1a Y Y Cancer-related genes, predicted intracellular proteins
Cry2 Y Y Y Predicted intracellular proteins
Per2 Y Disease-related genes, predicted intracellular proteins
Per3 Y Y Disease-related genes, predicted intracellular proteins
Wee1 Y Cancer-related genes, enzymes, plasma proteins, Predictedintracellular proteins
Rcan1 Y Y Predicted intracellular proteins
Slc41a3 Y Predicted membrane proteins, transporters
Errfi1 Y Y Y Predicted intracellular proteins
Bhlhe41 Y Predicted intracellular proteins, transcription factors
Table 4. Molecular signaling activities of 12 overlapping differentially expressed genes.
Term Description Genes
RNA polymerase II-specific DNA-binding transcription factor binding Arntl, Bhlhe41, Cry2, Per2
Kinase binding Cdkn1a, Cry2, Errfi1, Per2, Per3
Transcription regulatory region sequence-specific DNA binding Arntl, Bhlhe41, Cry2, Per2
Histone deacetylase binding Bhlhe41, Per2
SH3 domain binding Adam19, Errfi1
Nuclear hormone receptor binding Cry2, Per2
Transcription regulator activity Arntl, Bhlhe41, Cry2, Per2
Signaling receptor binding Arntl, Cry2, Per2, Spon2
Protein kinase activity Wee1
Nucleic acid binding Rcan1
Cation transmembrane transporter activity Slc41a3
Table 5. Intracellular pathways involvement of 12 overlapping differentially expressed genes.
Spon2 Adam19 Arntl Cdkn1a Cry2 Per2 Per3 Wee1 Rcan1 Slc41a3 Errfi1 Bhlhe41
Circadian rhythm + + + + +
ErbB signaling pathway +
HIF-1 signaling pathway +
FoxO signaling pathway +
Cell cycle, circadian regulated + +
p53 signaling pathway +
PI3K-Akt signaling pathway +
Cellular senescence +
JAK-STAT signaling pathway +
Oxytocin signaling pathway + +
Transcriptional misregulation in cancer + +
Circadian entrainment + +
Acute myeloid leukemia +
Human Immuno-deficiency virus 1 infection +
Thyroid hormone signaling pathway +
3.6. Microarray Analysis and Validation
To validate our microarray analysis findings of the 12 overlapping DEGs across
the three different radiation groups (Figure 4A–F), we tested five DEGs, namely period
circadian regulator 3 (Per3), basic helix-loop-helix family member E41 (Bhlhe41), cyclin-
dependent kinase inhibitor 1A (Cdkn1a), solute carrier family 41 member 3 (Slc41A3),
and aryl hydrocarbon receptor nuclear translocator like (Arntl), by qRT-PCR. Our qRT-
PCR analysis revealed that only Per3 was found significantly regulated in all conditions
(Figure 5A–E vs. Figure 4C–E). We also found that Bhlhe41, Cdkn1a, Slc41A3, and Arntl
were all significantly upregulated after 137Cs-IR exposure in a dose–response manner.
However, only Bhlhe41 was found to be upregulated in the 22Ti-IR group at high doses.
Our results also showed that Cdkn1 and Slc41A3 were significantly downregulated post-
16Si-IR exposure, while Arntl was found to be significantly upregulated at lower doses (8Si).
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Figure 5. qRT-PCR validation of 5 of 12 common differentially expressed genes across all radiation types: mNA expression of
(A) Per3, (B) Bhlhe41, (C) Cdkn1a, (D) Slc41a3, and (E) Arntl was measured by qRT-PCR in heart tissue (n = 3 heart/group).
Data were normalized using 18S rRNA. * p < 0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001 compared to control groups.
Per3, period circadian regulator 3; Bhlhe41, basic helix-loop-helix family member E41; Cdkn1a, cyclin-dependent kinase
inhibitor 1A; Arntl, aryl hydrocarbon receptor nuclear translocator like; Slc41a3, solute carrier family 41 member 3.
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3.7. Gene Enrichment Analysis of 12 Common DEGs
To further identify potentially compromised biological pathways, we performed a com-
prehensive gene set enrichment analysis for the 12 common genes (Spon2, Adam19, Arntl,
Cdkn1a, Cry2, Per2, Per3, Wee1, Rcan1, Slc41a3, Errfi1, and Bhlhe41) across all three radiation
types using Enrichr and pathway databases such as the 2019 Kyoto Encyclopedia of Genes
and Genomes (KEGG) for Mouse (Figure 6). KEGG pathway enrichment analysis revealed
that pathways associated with circadian rhythms, cancer (thyroid, bladder, endometrial,
non-small-cell lung cancer), the cell cycle, and the oxytocin signaling pathway were the
most enriched by these DEGs (Figure 6A–C). We then evaluated these DEGs against the
ChIP-X enrichment analysis (ChEA) gene set library to calculate enrichment for upstream
transcription factors. The ChEA 2016 database is a gene set library that contains putative
targets for transcription factors, based on reports profiling transcription factors binding to
DNA in mammalian cells. This analysis identified 10 transcription factors (CLOCK, TCF21,
AR, SALL4, SMAD2, SMAD3, PPAR, OCT4, CDX2, and CEBPB) that may be involved in the
regulation of the 12 common DEGs across the three types of radiation (Figure 6D–F).
Figure 6. A comprehensive gene set enrichment analysis for the 12 common genes differentially regulated across all
3 radiation groups was performed using EnrichR and the Kyoto Encyclopedia of Genes and Genomes (KEGG) 2019 Mouse
database and ChIP-X enrichment analysis (ChEA) gene set library. (A) Bar graphs (sorted by p-value ranking) represent the
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significance of that specific gene set using the KEGG 2019 Mouse database. The brighter the color, the more significant that
term. (B) The clustergrammer is sorted by combined scores (p-value and z-score) and shows heatmaps. Enriched terms are
shown as columns and input genes as rows to understand the relationships between input genes and enriched terms. Cells
in the matrix indicate whether a gene is associated with the indicated term. (C) The table shows a raw view of the data
and is sorted by p-value. Terms, z-score, odds ratio, and combined score are indicated. (D) Bar graphs (sorted by p-value
ranking) represent the significance of identified upstream transcription factors using the ChEA 2016 gene set library. The
brighter the color, the more significant the transcription factor (TF). (E) The clustergrammer is sorted by p-value and shows
heatmaps of enriched terms as columns. Input genes are shown as rows to understand the relationships between the input
genes and enriched TFs. Cells in the matrix indicate whether a gene is associated with the predicted TF. (F) The table shows
a raw view of the data and is sorted by p-value. Terms, z-score, odds ratio, and combined score are indicated.
Further enrichment analysis revealed that 14Si-IR exposure dysregulated 213 biological
processes in the heart tissue, whereas 137Cs-IR exposure alone affected 1040 biological
processes, and 22Ti-IR exposure dysregulated 302 biological processes. Interestingly, we
found 61 overlapping biological processes that were common for all three radiation groups
compared to controls (Figure 7A). Top hits for biological processes included abnormal
circadian rhythm, colon cancer, Hutchinson–Gilford progeria syndrome, acute myocardial
infarction, type 1 diabetes, etc. (Figure 7B).
Figure 7. Overlapping biological processes: (A) Venn diagram analysis of differentially expressed genes across all three
different radiation exposure groups/doses compared to controls. In each paired test, the differentially expressed genes were
identified as a log2 fold change and p < 0.05. In the diagram, blue circles represent genes putatively affected by long-term
137Cs exposure, green circles represent genes influenced by 14Si exposure, and yellow circles represent genes that were
putatively affected by 22Ti exposure. (B) The table represents various biological processes that are common for all three
radiation groups.
Finally, we were interested in understanding the extent of the genes and associated bio-
logical processes that were shared between particle doses causing the maximal effect (137Cs
at 160 cGy, 14Si at 4cGy, and 22Ti at 6.5 cGy). The analysis showed little overlap in terms
of up- or downregulated genes (Supplemental Figure S4A–D). Four upregulated overlap-
ping gene sets were detected in all three conditions, and more when performing pairwise
comparisons (Supplemental Figure S4A–D). While non-overlapping, each pairwise com-
parison revealed a considerable number of heart-disease-related gene sets, suggesting that
particle irradiation may affect cardiac function through various mechanisms. No common
downregulated gene sets were detected (Supplementary Table S6).
3.8. Regression Analysis of Common Differentially Expressed Genes across Radiation Type
Next, we assessed the 12 overlapping DEGs using dose-dependent regression analyses
(see the Materials and Methods section for details). Our findings revealed an exclusive
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non-linear differential gene expression pattern in 14Si- and 22Ti-IR-exposed hearts, whereas
two-thirds (66.7%) of 137Cs-IR-exposed hearts revealed a linear pattern of gene expression
(Figure 8A,B and Table 6). Further, dose–response shape-based clustering confirmed the
predominantly linear response in 137Cs-IR-exposed and non-linear responses in 14Si- and
22Ti-IR-exposed hearts (Figure 8C,D).
Figure 8. Dose–response analyses of expression of 12 genes commonly deregulated in all three radiation conditions:
(A,B) expression profile–exposure dosage analysis indicates that 137Cs irradiation mostly causes linear changes in gene
expression, while irradiation with 14Si and 22Ti mainly induces a non-linear gene expression response. (C–E) Heatmap
clustering of non-linear regression fit coefficients for 12 common genes in 137Cs-, 14Si-, and 22Ti-IR groups, respectively. The
columns in heatmaps represent non-linear fit coefficients.
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Table 6. Regression analyses of differentially expressed genes.
Icons 137Cs 14Si 22Ti
Type of Regression Linear Regression 423 0 1
Non-Linear Regression 215 53 123
4. Discussion
We used archived mouse hearts from NASA’s Space Radiation Tissue Sharing Fo-
rum collected from non-tumor-bearing female CB6F1/Hsd mice after single whole-body
irradiation with different low or very low doses of 137Cs-gamma, 14Si, or 22Ti-ion IR to
determine the long-term effects of radiation exposure on gene expression in the whole
heart as a function of IR type and dose compared to sham-treated controls. We aimed to
determine whether high-LET HZE particle-IR exposure may induce biological responses at
lower doses compared to 137Cs-gamma IR exposure. Our data revealed a dose-dependent
increase in the number of DEGs (both up- and downregulated) following exposure to
increasing doses of 137Cs-IR, while no discernable pattern of DEGs was observed in hearts
irradiated with 14Si or 22Ti-ion. In contrast to 137Cs-gamma IR, where the largest num-
ber of DEGs was observed after the highest dose (160 cGy), the largest number of DEGs
was observed at the lowest dose of 14Si-IR (4 cGy) and the second-lowest dose of 22Ti-IR
(6.5 cGy), suggesting that compared to 137Cs-gamma IR, even low doses of HZE-IR may be
sufficient to induce long-term dysregulation of genes in the heart tissue. In the 14Si-ion IR
group (260 MeV/n), no DEGs were detected at an intermediate dose of 16 cGy but were
detected at the higher dose of 32 cGy, while the lowest number or absence of DEGs was
observed at minimum and maximum doses of 22Ti-ion IR (3 and 26 cGy, 1 GeV/n). It is
possible the effects of these radiation types and respective doses may be too subtle for the
detection of DEGs based on statistical criteria or may have resulted in extensive damage
of a few heavily damaged cells at the cellular level, resulting in early death and clearance
of the affected cells without long-term consequences on the gene expression in the whole
tissue. Considering that low doses of HZE-ion IR may be sufficient to induce changes in
genes involved in disease pathophysiology, further studies are needed to better delineate
the effects of these radiation types and doses, along with the mechanisms triggering these
varied responses, in order to develop better assessments of radiobiological effectiveness.
Among all groups, irrespective of radiation type or dose, no clear lower IR threshold
for gene expression was detected. However, the gene signatures were indicative of varying
cardiovascular diseases such as hypertension, atherosclerosis, cardiomyopathies (non-
ischemic, dilated, peripartum, hypertrophic), heart failure, acute myocardial injury, and
myocarditis, as well as known cardiovascular risk factors, including but not limited to
obstructive sleep apnea, idiopathic lung fibrosis, diabetes, and obesity. It is therefore
of utmost importance to further investigate the disrupted pathways and linked gene
networks to determine the presence of early biomarkers for disease risk and/or inform
the development of mitigating factors for radiation-induced cardiovascular and other
degenerative diseases during and after exploration-type spaceflight missions.
We identified 12 genes differentially regulated at at least one or more doses of all three
radiation types. These include Spon2, Adam19, Arntl, Cdkn1a, Cry2, Per2, Per3, Wee1,
Rcan1, Slc41a3, Errfi1, and Bhlhe41, which are related to numerous cardiovascular and de-
generative diseases of other organs as well as varying aging processes. For example, Spon2
encodes mindin, an extracellular matrix protein highly expressed in cardiac tissue, and
plays various roles, including (1) serving as a ligand for integrin during inflammation [37],
(2) inhibiting angiogenesis [38], and (3) playing an anti-hypertrophic role, protecting against
cardiac remodeling observed in heart failure by attenuating AKT/GSK3β and TGF-β1-
Smad signaling [39]. We also found cyclin-dependent kinase inhibitor 1A (Cdkn1A), also
known as p21, to be dysregulated with different radiation types/doses, which correlates
with previously published reports [40]. P21 is a well-known potent universal CDK in-
hibitor [41] and regulates diverse biological functions such as cell growth, proliferation,
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apoptosis, and inflammation [42,43]. It has been primarily described as a major regulator
of p53-dependent cell cycle arrest in response to DNA damage. Previous aging studies
reported that p21-knockout mice were more susceptible to developing spontaneous tumors
and exhibited early tumor onset and more severe atherosclerotic lesions compared to
wild-type mice [44,45].
Interestingly, among the 12 identified overlapping genes, 5 are directly related to the
regulation of circadian rhythms: Per2, Per3, Cry2, Bhlhe41, and Arntl [46]. In addition to
these circadian-rhythm-associated genes, we also identified the upstream transcription
factor CLOCK [47], predicted to be upregulated across all radiation types/doses. The fun-
damental role of circadian rhythms is the diurnal regulation of behavior and physiological
processes over 24 h, and they are of interest in spaceflight, considering the entrainment
signals of light/dark are disrupted during low-Earth-orbit (LEO) flights [48] and are ex-
pected to be disrupted during future exploration-type space missions. Recent studies have
highlighted the critical role of circadian rhythms in regulating cardiac metabolism, function,
and response to injury [49].
The diurnal regulation of circadian rhythms involves feedback loops of transcription
and translation. The CLOCK gene has DNA-binding histone acetyltransferase activity.
It plays a critical role in regulating circadian rhythms by forming heterodimers with
other clock proteins such as Arntl and promoting transcription of period (Per1, Per2,
and Per3) [50] and cryptochrome (Cry1, Cry2) genes [46]. Per2 has been shown to play a
cardioprotective role in myocardial ischemia. Its dysregulation is associated with increased
cardiovascular disease risk as a result of impaired metabolic pathways, including fatty acid
metabolism, cardiac anaerobic glycolysis, other pathways involved in vascular senescence
and endothelial dysfunction, and dysregulation of cardiac ion channels, which play critical
roles in the development of arrhythmias [51–55]. Such dysregulation may also result
in the development of endothelial and vascular phenotypes observed in cardiovascular
disease. Per3 is involved in delayed sleep-phase syndrome and cardiac autonomic control
during sleep [56]. Considering its multifaceted regulatory roles, the disruption of circadian
rhythms can potentially play a large role in many disease processes associated with low-
dose space-type radiation.
We observed downregulation of Arntl with increasing doses of 137Cs-gamma IR,
whereas 14Si-ion IR exposure up to 8 cGy significantly upregulated Artnl. 22Ti-ion IR
did have a significant effect on Arntl expression at any dose. Differences in the radiation
quality may be important to this observation as the silicon ions were 70 keV/mm, and
the titanium were 100 keV/mm with greater ionization densities. Altered levels of Arntl
have been associated with increased susceptibility to hypertension, diabetes, obesity, and
defective lipogenesis [57,58]. Per3 expression dose-dependently followed 137Cs-gamma IR,
whereas higher doses of 14Si- ion IR (16 and 32 cGy) and 22Ti-ion IR (greater than 6.5 cGy)
exhibited increased Per3 expression. Furthermore, defects in Bhlhe41, a transcription
factor repressor in circadian rhythms, are associated with altered sleep patterns [59] and
are reported to play a significant role in immune function [60], as well as epithelial-to-
mesenchymal transition [61]. Bhlhe41 expression was elevated at all 137Cs-gamma IR doses,
whereas no effect on expression was noted across all doses of 14Si-ion IR. Higher doses
of 22Ti-ion IR (6.5–26 cGy) significantly increased Bhlhe41 expression. The differential
regulation of CLOCK genes can disrupt components downstream to the circadian cycle
regulatory mechanism. Thus, regulation of the circadian rhythm genes may represent
a potential mitigation mechanism for the well-being of astronauts during long-duration
space missions [62].
In addition to CLOCK, our gene enrichment analysis identified nine other transcrip-
tions factors (TCF21, AR, SLAL4, SMAD2, SMAD3, OOAR, OCT4, CDX2, and CEBPB),
which are implicated in various cellular processes, including metabolism [63,64], inflamma-
tion [65–67], rhythmic activation of circadian cycle repressors [68], and maintenance of the
pluripotency of stem cells [69–72]. Many of these factors act as key mediators of canonical
signaling pathways such as SMAD2 and SMAD3, involved in TGF-β signaling. They, thus,
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are involved in cell proliferation, apoptosis, and differentiation [73–76]. Additionally, many
play important roles in tumor processes, including tumor-associated angiogenesis and
induction of epithelial-to-mesenchymal cell transitioning [77–82]. Thus, there are many
potential avenues to explore to understand and mitigate the cardiovascular response in the
setting of radiation exposure during spaceflight.
There are few limitations worth mentioning. First, we used a relaxed cutoff threshold
(adjusted p < 0.25), which could include more false positives compared to a stricter cutoff.
In contrast, it is well known that a small sample size generally yields higher adjusted
p-values [83–86]. However, the results of downstream functional analyses and data from
previous publications further confirmed the validity of our methodology and findings.
5. Conclusions
In this study, we demonstrated that exposure to ionizing radiation causes a change
in the transcriptomic profile of hearts from whole-body-irradiated mouse hearts that is
dependent on the quality and quantity of radiation. The effects of low-LET 137Cs-gamma
rays and high-LET 14Si- and 22Ti-ion IR are distinctly different, yet none presented a clear
lower IR threshold for differential gene expression in this study. Dose-dependent regression
analyses of the 12 identified differentially expressed common genes for all three radiation
types showed a dose-dependent linear response in 67% (8/12) of the genes following
137Cs-gamma IR, consistent with changes induced in the whole transcriptomic profile
after this type of IR exposure. At the same time, there was an exclusive non-linear DEG
pattern with 14Si- or 22Ti-ion IR. Moreover, HZE-ion IR-exposed hearts showed the largest
change in gene expression at lower doses, indicating a greater biological response at low
and very low doses, in part, due to the different quality of HZE-ion IR-induced tissue
damage. Multiple genes involved in cardiovascular and other degenerative diseases were
attenuated with exposure to all three radiation types. Overall, the data in this manuscript
points to metrics in the form of differential gene expression that could be used in assessing
cardiovascular risks astronauts face during deep-space missions but also risks for other
neurodegenerative diseases, aging processes, and cancers of various organs. However,
future mechanistic and functional studies, including acute, intermediate, and late time
points using additional lower doses to determine a possible lower threshold, would give
us a comprehensive understanding of HZE-ion IR’s effects on human health and disease.
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